Breaking News Instant updates and real-time market news.

TEVA

Teva

$37.97

0.1125 (0.30%)

10:25
11/30/16
11/30
10:25
11/30/16
10:25

Rumor: Teva active amid renewed takeover speculation

  • 30

    Nov

TEVA Teva
$37.97

0.1125 (0.30%)

11/16/16
11/16/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Sysco (SYY) downgraded to Neutral from Outperform at Credit Suisse with analyst Edward Kelly saying Sysco shares are up 50% over the last 18 months and now views risk/reward as balanced. 2. Teva (TEVA) downgraded to Hold from Buy at Jefferies, to Equal Weight from Overweight at Morgan Stanley, and to Neutral from Buy at BTIG. 3. Bank of America (BAC) Capital One (COF) downgraded to Neutral from Outperform at Baird while the firm downgraded Fifth Third (FITB) to Underperform from Neutral. 4. Zions Bancorp (ZION) downgraded to Equal Weight from Overweight at Morgan Stanley and to Market Perform from Outperform at Bernstein. 5. Yingli Green Energy (YGE) downgraded to Sell from Buy at Axiom while the firm downgraded SolarCity (SCTY) and JA Solar (JASO) to Sell from Hold. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/17/16
MAXM
11/17/16
NO CHANGE
Target $52
MAXM
Buy
Teva price target lowered to $52 from $72 at Maxim
Maxim analyst Gabrielle Zhou lowered her price target for Teva to $52 from $72 after the company reported Q3 results and cut it full-year guidance. The analyst notes that the company has started its Actavis integration, with the latter now contributing to Teva's generic revenues. However, she believes Teva needs to focus now on growth, noting that 2017 will be a challenge. Zhou reiterates a Buy rating on Teva's shares.
11/22/16
LEER
11/22/16
NO CHANGE
LEER
Outperform
Alder Biopharmaceuticals patent fight far from over, says Leerink
Leerink analyst Joseph Schwartz says Alder Biopharmaceuticals (ALDR) stated that the European Patent Office issued a ruling revoking all claims in its competitor Teva's (TEVA) patent relating to CGRP antagonist antibodies but maintaining and narrowing claims relating to the use of CGRP antagonist antibodies in human therapy to the prevention or treatment of headache such as migraine and cluster headache. The analyst notes that the persistence of the headache claims has concerned investors, but points out that Alder believes the patent fight is far from over in the EU, or moreover in the U.S. Schwartz reiterates an Outperform rating on Alder's shares.
11/25/16
PIPR
11/25/16
NO CHANGE
Target $47
PIPR
Overweight
Alder recent selloff an overreaction, says Piper Jaffray
Piper Jaffray analyst Charles Duncan attributes the recent weakness in shares of Alder Biopharmaceuticals (ALDR) to "increased visibility and outcome uncertainty" for the company's challenge to Teva's (TEVA) anti-CGRP patents in the U.S. and Europe. The analyst views the selloff as an overreaction and remains focused on his "clinical data-driven thesis for the emerging, differentiated profile of lead candidate ALD403." Duncan keeps an Overweight rating on Alder with a $47 price target.

TODAY'S FREE FLY STORIES

MLNX

Mellanox

$64.30

-0.45 (-0.69%)

17:12
01/17/18
01/17
17:12
01/17/18
17:12
Hot Stocks
Starboard to nominate nine directors for election at Mellanox »

Starboard Value, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

APHB

AmpliPhi

$1.12

0.03 (2.75%)

17:11
01/17/18
01/17
17:11
01/17/18
17:11
Syndicate
AmpliPhi requests withdrawal of registration statement »

AmpliPhi confirms that no…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$146.98

0.12 (0.08%)

17:05
01/17/18
01/17
17:05
01/17/18
17:05
Hot Stocks
Johnson & Johnson issues statement on ZYTIGA Inter Partes reviews »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 16

    Feb

  • 08

    Mar

EVEP

EV Energy

$0.89

0.015 (1.71%)

17:03
01/17/18
01/17
17:03
01/17/18
17:03
Hot Stocks
EV Energy announces extension of grace period to meet NASDAQ requirement »

EV Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBM

Hudbay Minerals

$10.05

0.1 (1.01%)

17:02
01/17/18
01/17
17:02
01/17/18
17:02
Hot Stocks
Hudbay Minerals sees FY18 CapEx $245M »

Hudbay Minerals released…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFE

Safeguard Scientifics

$10.85

-0.15 (-1.36%)

17:02
01/17/18
01/17
17:02
01/17/18
17:02
Hot Stocks
Safeguard Scientifics to implement changes in business strategy and operations »

Safeguard Scientifics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSI

Motorola Solutions

$97.28

1.42 (1.48%)

, SSTI

ShotSpotter

$16.10

0.06 (0.37%)

16:55
01/17/18
01/17
16:55
01/17/18
16:55
Hot Stocks
Motorola Solutions reports 9.8% passive stake in ShotSpotter »

In a regulatory filing,…

MSI

Motorola Solutions

$97.28

1.42 (1.48%)

SSTI

ShotSpotter

$16.10

0.06 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

ERIE

Erie Indemnity

$117.23

1.44 (1.24%)

16:52
01/17/18
01/17
16:52
01/17/18
16:52
Hot Stocks
Erie Indemnity sees $20M in tax expense as a result of new tax law »

Erie Indemnity expects to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.10

2.91 (1.65%)

16:52
01/17/18
01/17
16:52
01/17/18
16:52
Periodicals
Apple to issue $2,500 restricted stock bonuses to workers, Bloomberg says »

Apple informed its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

SLM

Sallie Mae

$11.49

0.02 (0.17%)

16:51
01/17/18
01/17
16:51
01/17/18
16:51
Earnings
Sallie Mae reports Q4 core EPS 19c, consensus 19c »

Reports Q4 GAAP net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

16:45
01/17/18
01/17
16:45
01/17/18
16:45
General news
Treasury TIC flows: foreign accounts bought $33.8 B in total U.S. assets »

Treasury TIC flows:…

VZ

Verizon

$51.72

0.06 (0.12%)

16:43
01/17/18
01/17
16:43
01/17/18
16:43
Hot Stocks
Verizon to record cumulative adjustment to retained earnings during 1Q18 »

Verizon said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

VZ

Verizon

$51.72

0.06 (0.12%)

16:42
01/17/18
01/17
16:42
01/17/18
16:42
Hot Stocks
Verizon sees $4.10 impact to FY17 EPS after tax reform »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

BELFA

Bel Fuse

, BELFB

Bel Fuse

$24.70

0.25 (1.02%)

16:39
01/17/18
01/17
16:39
01/17/18
16:39
Earnings
Bel Fuse anticipates Q4 revenue $120M, 1 estimate $124M »

The company's…

BELFA

Bel Fuse

BELFB

Bel Fuse

$24.70

0.25 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:37
01/17/18
01/17
16:37
01/17/18
16:37
General news
API crude inventories for week of January 12 »

API reports that crude…

SLM

Sallie Mae

$11.49

0.02 (0.17%)

16:36
01/17/18
01/17
16:36
01/17/18
16:36
Earnings
Sallie Mae sees initial FY18 EPS 97c-$1.01, consensus $1.04 »

Sees FY18 private…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

AMGP

Antero Midstream GP

$20.89

-0.11 (-0.52%)

16:36
01/17/18
01/17
16:36
01/17/18
16:36
Hot Stocks
Antero Midstream GP provides distribution guidance for 2018 through 2022 »

Antero Midstream GP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

AR

Antero Resources

16:36
01/17/18
01/17
16:36
01/17/18
16:36
Hot Stocks
Antero Resources sees FY18 CapEx $1.45B »

Antero's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

AR

Antero Resources

16:35
01/17/18
01/17
16:35
01/17/18
16:35
Hot Stocks
Antero Resources sees Q4 net daily gas equivalent production 2,347 MMcfe/d »

Preliminary Fourth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

HBHC

Hancock Holding

$54.45

0.9 (1.68%)

16:35
01/17/18
01/17
16:35
01/17/18
16:35
Earnings
Hancock Holding reports Q4 EPS with items 64c, consensus 83c »

The fourth quarter of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

AR

Antero Resources

16:34
01/17/18
01/17
16:34
01/17/18
16:34
Hot Stocks
Antero Resources sees net daily production approximately 2.7 Bcfe/d in 2018 »

2018 Guidance and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

AM

Antero Midstream Partners

$30.95

-0.8 (-2.52%)

16:33
01/17/18
01/17
16:33
01/17/18
16:33
Hot Stocks
Antero Midstream Partners provides 2018 and long-term target guidance »

Antero Midstream provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

SBOW

SilverBow Resources

$31.48

0.52 (1.68%)

16:32
01/17/18
01/17
16:32
01/17/18
16:32
Hot Stocks
SilverBow Resources sees 2018 capital program of $245M-$265M »

SilverBow Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

RDN

Radian Group

$22.26

0.13 (0.59%)

16:31
01/17/18
01/17
16:31
01/17/18
16:31
Hot Stocks
Radian Group updates on capital actions »

Radian Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HES

Hess Corp.

$54.02

0.48 (0.90%)

16:30
01/17/18
01/17
16:30
01/17/18
16:30
Initiation
Hess Corp. initiated  »

Hess Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.